MedTrace Logo

Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday

NCT01854086 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2013-05-15

No results posted yet for this study

Summary

The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and concerns about future treatments in patients during "drug holiday".

Conditions

Interventions

OTHER

Questionnaires about compliance and persistence with bisphosphonates treatment

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-02-28

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01854086 on ClinicalTrials.gov